Therapeutic Recommendations for the Treatment of Toenail Onychomycosis in the US

Shari Lipner; Warren  Joseph; Tracey Vlahovic; Richard Scher; Phoebe Rich; Mahmoud Ghannoum; Ralph Daniel; Boni Elewski

doi:10.25251/skin.6.supp.s31

Shari Lipner

Weill Cornell Medical College, New York, NY

Warren Joseph

Arizona College of Podiatric Medicine

Tracey Vlahovic

Temple University School of Podiatric Medicine, Philadelphia, PA

Richard Scher

Weill Cornell Medical College, New York, NY

Phoebe Rich

Oregon Health & Science University, Portland, OR

Mahmoud Ghannoum

Case Western Reserve University and University Hospitals, Cleveland, OH, USA

Ralph Daniel

University of Mississippi Medical Center

Boni Elewski

University of Alabama at Birmingham School of Medicine, Birmingham, AL

Keywords

Onychomycosis

Abstract

N/A

References

1. Gupta AK, Paquet M. J Cutan Med Surg. 2015;19(3):260-273.

2. Ghannoum MA, Hajjeh RA, Scher R, et al. J Am Acad
Dermatol. 2000;43(4):641-648.

3. Rosen T, Friedlander SF, Kircik L, et al.
J Drugs Dermatol. 2015;14(3):223-233.

4. Gupta AK, Stec N. F1000Res. 2019;8.

5. Tosti A, Elewski BE. Skin Appendage Disord. 2016;2(1-2):83-87.

6. Narasimha Murthy S, Wiskirchen DE, Bowers CP. J Pharm Sci.

2007;96(2):305-311.

7. Ameen M, Lear JT, Madan V, et al. Br J Dermatol.
2014;171(5):937-958.

8. Burkhart CN, Burkhart CG, Gupta AK. J Am Acad Dermatol.
2002;47(4):629-631.

9. Roberts DT, Evans EG. Br J Dermatol. 1998;138(1):189-190.

10. Wang C, Cantrell W, Canava

Poster PDF

Published

Mar 4, 2022

DOI https://doi.org/10.25251/skin.6.supp.s31

How to Cite

Lipner, S., Joseph , W. ., Vlahovic, T., Scher, R., Rich, P., Ghannoum, M., Daniel, R., & Elewski, B. (2022). Therapeutic Recommendations for the Treatment of Toenail Onychomycosis in the US. SKIN The Journal of Cutaneous Medicine, 6(2), s31. https://doi.org/10.25251/skin.6.supp.s31

Issue

Vol. 6 No. 2 (2022): March Issue and Poster Presentations (FC PANP 21 and WC 22 Dermatology Conferences®)

Section

Miscellaneous

This work is licensed under a Creative Commons Attribution 4.0 International License.

All authors retain copyright in their articles. All articles published open access allowing for immediate free access to the work and permitting any user to read, download, copy, distribute, print, search, or link to the full texts of articles, crawl them for indexing, pass them as data to software or use them for any other lawful purpose. Permitted reuse is defined by the following user license:

Creative Commons Attribution (CC BY): lets others distribute and copy the article, to create extracts, abstracts, and other revised versions, adaptations or derivative works of or from an article (such as a translation), to include in a collective work (such as an anthology), to text or data mine the article, even for commercial purposes, as long as they credit the author(s), do not represent the author as endorsing their adaptation of the article, and do not modify the article in such a way as to damage the author's honor or reputation.

Authors retain copyright in their work and license the publisher to publish the content. The publisher is the National Society for Cutaneous Medicine, with production and publishing support provided by OJS, Open Journal Systems,see https://pkp.sfu.ca/ojs/.

Prior to January 2022, authors transferred copyright to the National Society for Cutaneous Medicine. However, all articles are freely available to anyone in the world. There are no subscription fees, page charges, or article processing charges.

Most read articles by the same author(s)

Meredith Burns, Timothy Orlowski, Hoang Ho-Pham, Carly Elston, Boni Elewski, New Onset Generalized Pustular Psoriasis Rapidly Improved with IL-36 Blockade , SKIN The Journal of Cutaneous Medicine: Vol. 7 No. 1 (2023)
Andrew Blauvelt, Phoebe Rich, Howard Sofen, Jo Lambert, Joe Merola, Mark Lebwohl, Lauren Hippeli, Renata Kisa, Subhashis Banerjee, Alexa Kimball, Deucravacitinib, an oral, selective tyrosine kinase 2 inhibitor, versus placebo in scalp, nail, and palmoplantar psoriasis: subset analyses of the phase 3 POETYK PSO-1 and PSO-2 trials , SKIN The Journal of Cutaneous Medicine: Vol. 6 No. 4 (2022): July 2022 Issue
Angela Moore, Suzanne Bruce, Neil Sadick, Eduardo Tschen, Philip Werschler, Sunil Dhawan, Douglas Farsha, Michael Gold, Scott Guenthner, Steve Kempers, Leon Kircik, Jennifer Parish, Marta Rendon, Phoebe Rich, Linda Stein-Gold, Stephen Tyring, Robert Weiss, Adnan Nasir, Carsten Schmitz, Terry Boodhoo, Alexandre Kaoukhov, David Berk, Fran Cook-Bolden, Ayman Grada, Once-Daily Oral Sarecycline 1.5 mg/kg/day is Effective for Moderate to Severe Acne Vulgaris: Results from Two 12-Week, Phase 3, Randomized, Double-Blind Clinical Trials , SKIN The Journal of Cutaneous Medicine: Vol. 4 No. 5 (2020): September Issue & Poster Presentations (FCPANP20® Dermatology Conference)
Andrew Blauvelt, Phoebe Rich, Howard Sofen, Jo Lambert, Joseph F Merola, Mark Lebwohl, Thomas Scharnitz, Kim Hoyt, Renata M Kisa, Subhashis Banerjee, Deucravacitinib, an oral, selective, allosteric tyrosine kinase 2 inhibitor, in scalp, nail, and palmoplantar psoriasis: subgroup analyses of the phase 3 POETYK PSO-1 and PSO-2 trials , SKIN The Journal of Cutaneous Medicine: Vol. 6 No. 6 (2022): November Issue & Poster Presentations from FC22 Dermatology Conference®
Stephan Weidinger, Jonathan Silverberg, Darryl Toth, Thomas Bieber, Andrew Alexis, Boni Elewski, Andrew Pink, DirkJan Hignen, Efficacy and Safety of Tralokinumab Plus Concomitant Topical Corticosteroids (TCS) in Adult Patients with Moderate-to-Severe Atopic Dermatitis: Results from the 32-Week, Phase 3 ECZTRA 3 Trial , SKIN The Journal of Cutaneous Medicine: Vol. 4 No. 6 (2020): November Issue & Poster Presentations (FC20 Dermatology Conference®)
Hana Nasim Ahmed M.D., Meagan Mandabach Olivet, Carly Elston M.D., Boni Elewski M.D., Erythema Multiforme Is Not Always Erythema Multiforme , SKIN The Journal of Cutaneous Medicine: Vol. 6 No. 1 (2022)
Shari Lipner, Warren Josepth, Tracy Vlahovic, Richard Scher, Phoebe Rich, Mahmoud Ghannoum, Ralph Daniel, Boni Elewski, Therapeutic Recommendations for the Treatment of Toenail Onychomycosis in the US , SKIN The Journal of Cutaneous Medicine: Vol. 5 No. 6 (2021): November Issue & Poster Presentations (FC21 Dermatology Conference®)
Lawrence F Eichenfield, Boni Elewski, Jeffrey L Sugarman, Ted Rosen, Aditya Gupta, Wendy Cantrell, Radhakrishnan Pillai, Abby Jacobson, Safety, Pharmacokinetics, and Efficacy of Efinaconazole 10% Topical Solution for the Treatment of Onychomycosis in Pediatric Patients , SKIN The Journal of Cutaneous Medicine: Vol. 4 No. 5 (2020): September Issue & Poster Presentations (FCPANP20® Dermatology Conference)
Boni Elewski, Matthew Zirwas, Azra Kurbasic, Shannon Schneider, Ami Claxton, Jonathan Silverberg, Efficacy and Safety of Tralokinumab in US Adults with Moderate-to-Severe Atopic Dermatitis: A Post-hoc Analysis of ECZTRA3 , SKIN The Journal of Cutaneous Medicine: Vol. 7 No. 2 (2023): March Issue & Poster Presentations from WCH23 Dermatology Conference®
Boni Elewski, Alan Menter, Jeffrey Crowley, Stephen Tyring, Yang Zhao, Simon Lowry, Stephen Rozzo, Alan Mendelsohn, Jeffrey Parno, Kenneth Gordon, Sustained and Improved Efficacy of Tildrakizumab from Week 28 to Week 52 in Treating Moderate-to-Severe Plaque Psoriasis , SKIN The Journal of Cutaneous Medicine: Vol. 2 (2018): Supplemental Issue: Scientific Posters Presented at 2018 Winter Clinical Dermatology Conference®-Hawaii

1 2 3 > >>

Main Article Content

Keywords

Abstract

References

Article Sidebar

Article Details

Similar Articles

Most read articles by the same author(s)